ArticleBMJ open2025

Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial): a randomised controlled trial protocol.

Siddharth Chhajlani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.